CD4 and Hepatic fibrosis: Prospective study revealed that CD4+CD45RO+ lymphocyte telomere lengths predicted the response to antiviral therapy in chronic HCV infection, independent of age, sex, HCV genotype, BMI and hepatic fibrosis, all factors that have been identified previously as predicting the response to antiviral therapy [21,29].